Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of British Columbia
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)